International Hepatology

A research team led by Dr. Dong Zhang and Dr. Guangyong Sun from Beijing Chaoyang Hospital, Capital Medical University, in collaboration with Dr. Zhongtao Zhang from Beijing Friendship Hospital, Capital…

Today, we join the global community in recognizing World Hepatitis Day. This year’s theme, "Eliminate Hepatitis · Take Action Positively," underscores the importance of proactive measures in combating this liver…

Introduction: Interventional therapy is an emerging clinical discipline and a key component of minimally invasive medicine. It stands as an independent field alongside traditional internal medicine and surgery, forming the…

Autoimmune hepatitis (AIH) presents ongoing challenges in diagnosis and treatment, requiring continuous research to improve patient outcomes. Professor Michael A. Heneghan has been a leading voice in AIH research, providing…

Editor's Note: China has a high incidence of liver cancer, with most patients being diagnosed at an advanced stage, losing the opportunity for surgical cure. Currently, the treatment for advanced…

From February 20 to 22, 2025, the European Association for the Study of the Liver (EASL) Liver Cancer Summit was held in Paris, France. The first day of the conference was dedicated to Cholangiocarcinoma (CCA). Dr. Chiara Braconi, a leading expert in cholangiocarcinoma treatment from the University of Glasgow, UK, delivered a keynote lecture and later sat down for an exclusive interview with our publication.

Editorial Note: Bicyclol (4,4'-dimethoxy-5,6,5',6'-bis(methylenedioxy)-2-hydroxymethyl-2'-methoxycarbonylbiphenyl) is a derivative of Schisandra chinensis, a traditional Chinese medicine. In recent years, it has demonstrated remarkable efficacy and safety in the treatment of liver diseases.…

Budd-Chiari Syndrome (BCS) is a complex and severe vascular liver disease that poses significant challenges to patients' health and survival. Transjugular intrahepatic portosystemic shunt (TIPS), a minimally invasive interventional procedure,…

Editor’s Note: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease in children aged 2 to 19, affecting approximately 1 in 10 children. Recently, a research…

Editor’s Note: Chronic hepatitis B (CHB) remains a major global health challenge, causing over 820,000 deaths annually, primarily due to virus-related liver cirrhosis and hepatocellular carcinoma (HCC). Throughout different stages…